3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Withdrawn
1
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Esophageal Neoplasms
9
Melanoma
6
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Small Cell Lung Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Carcinoma, Transitional Cell
2
Unresectable Biliary Tract Cancer
1
Thymus Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Small Cell Lung Cancer Extensive Stage
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Pathologic Complete Response
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Nasopharyngeal Neoplasms
1
Muscle-Invasive Bladder Carcinoma
1
Interventions
pembrolizumab
25
Cisplatin
17
Carboplatin
13
Radiotherapy
12
Cetuximab
9
Blood Specimen Collection
9
Docetaxel
8
Paclitaxel
7
Fluorouracil
7
Drug Therapy
7
toripalimab
6
tislelizumab
4
nimotuzumab
4
atezolizumab
4
Surveys and Questionnaires
4
Radiation
4
Chemoradiotherapy
4
fludarabine
3
Surgical Procedures, Operative
3
Standard of Care
3
Radiotherapy, Intensity-Modulated
3
Cyclophosphamide
3
Biopsy
3
130-nm albumin-bound paclitaxel
3
cemiplimab
2
avelumab
2
X-Rays
2
Tocopherols
2
Tiragolumab
2
Therapeutics
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Head and Neck Neoplasms
×
Immunotherapy
×
Clear all
NCT05328024
2026-06-05
IPRICE
Centre Paul Strauss
Recruiting
60 enrolled